Top Markets
#1 ADO Protocol ADO Protocol +194.72%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +40.11%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.15%
#6 TENDIES TENDIES +16.67%
#7 Wrapped NXM Wrapped NXM +14.87%
#8 Verus Coin Verus Coin +13.64%
#9 Tutorial Tutorial +13.32%
#10 Pons Pons +12.61%
Coin of the day
ADO Protocol ADO Protocol
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Clasificación en acciones #33738
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Precio por acción
$4.58
Última sincronización: 2025-05-09
Capitalización bursátil
$6.98M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio NeuroMetrix, Inc. (NURO)

Categoría

Healthcare
Ganancias de NeuroMetrix, Inc. (NURO)
Ganancias en Dec 2024 TTM: $-7.81M
Secondo gli ultimi rapporti finanziari di NeuroMetrix, Inc., gli utili attuali della società sono $-7.81M. Nel 2023, la società ha registrato un utile di $-6.53M, una disminución en comparación con agli utili del 2022, che erano di $-4.42M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de NeuroMetrix, Inc. desde 2001 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-7.81M 0.00%
2024 $-7.81M 19.55%
2023 $-6.53M 47.84%
2022 $-4.42M 93.58%
2021 $-2.28M 9.05%
2020 $-2.09M -44.55%
2019 $-3.77M -16,083.96%
2018 $23.61K -100.18%
2017 $-12.86M -13.77%
2016 $-14.91M 62.32%
2015 $-9.19M 18.30%
2014 $-7.77M -3.15%
2013 $-8.02M -19.87%
2012 $-10.01M 0.26%
2011 $-9.98M -41.33%
2010 $-17.01M -99.86%
2009 $-11.92B 56,302.52%
2008 $-21.13M 152.19%
2007 $-8.38M -287.82%
2006 $4.46M 358.34%
2005 $973.26K -100.01%
2004 $-13.51B 0.00%
2003 0.00 0.00%
2002 0.00 0.00%
2001 0.00 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -96,320.18%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -66,048.81%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -71,365.19%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -49,561.60%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -18,260.26%
US